Gilead Sciences Inc. (NASDAQ: GILD) issued $3 billion in senior notes through a public offering on May 20, 2026, according to a company statement.

The debt issuance consists of four tranches: $500 million in 4.250% senior notes due 2028, $1 billion in 4.400% senior notes due 2029, $1 billion in 4.600% senior notes due 2031, and $500 million in 4.900% senior notes due 2034. All notes will pay interest semi-annually.

The company entered into an Eleventh Supplemental Indenture with Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, serving as trustee. The supplemental indenture relates to the company's base indenture dated March 30, 2011.

Gilead stated it intends to use net proceeds for general corporate purposes, which may include funding for acquisitions, investments, strategic transactions or other business opportunities.

The indenture agreements contain restrictions limiting the company's ability and certain subsidiaries' ability to create or incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge or transfer substantially all assets. The agreements also require Gilead to offer to repurchase the notes upon certain change of control events.

The company may redeem some or all notes at any time at applicable redemption prices described in the note forms. The notes were sold pursuant to the company's Registration Statement on Form S-3.